Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes
PreDiabetes, Obesity, Insulin Resistance
About this trial
This is an interventional prevention trial for PreDiabetes focused on measuring pediatrics, prediabetes, obesity
Eligibility Criteria
Inclusion Criteria:
- Age 14 or older
- English-speaking
- stable metformin dose for 1 month prior to enrollment or no metformin use
- baseline A1c of 5.7-6.4%
- tanner stage 3 or above
- BMI > = 85% for age
Exclusion Criteria:
- BMI < 85% for age
- chronic steroid use
- diagnosis of type 1 diabetes, type 2 diabetes, other forms of diabetes
- current or history of malignancy
Sites / Locations
- Children's of AlabamaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
CGM + Traditional Counseling
Control
Subjects in this arm will receive intermittent CGM to be used for 2-weeks each month for the 6-month study period. They will be required to wear a CGM during baseline, 3-month, and 6-month periods. Additional CGM sensors will be supplied for months 1, 2, 4, and 5 and will be optional. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.
Subjects in this arm will receive standard medical care for pre-diabetes. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.